Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
FDA approves Banzel to treat seizures associated with LGS in pediatric patients
Corpus ID: 71133184
FDA has approved rufinamide (Banzel, Eisai) for the treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric…
Table of new antiepileptic drugs
Corpus ID: 71846500
Rufinamide (Banzel) For Lennox-Gastaut syndrome Adults:400-800 mg/day in 2 divided doses Peds: 4-10mg/kg/day in 2 divided doses…
Clobazam, ezogabine, and tafluprost.
Daniel A. Hussar
Sarah E. Hallinan
Journal of the American Pharmacists Association…
Corpus ID: 6665726
Antiepileptic drugs Clobazam Two new antiepileptic drugs (AEDs) were marketed in early 2012 and are considered individually in…
Severe constipation associated with the use of rufinamide (Banzel) in an adolescent
Kendra W Drake
Epilepsy & Behavior
Corpus ID: 26990247
Rufinamide (Banzel) for epilepsy.
The Medical letter on drugs and therapeutics
Corpus ID: 41967021
JAAPA : official journal of the American Academy…
Corpus ID: 43432138
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE